Retour
35
Fourchette du Jour
11,67 €
12,17 €
Fourchette 52 Semaines
11,61 €
24,60 €
Volume
919 456
Moyenne 50J / 200J
14,62 €
/
18,97 €
Clôture Précédente
12,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -20,0 | 0,2 |
| P/B | 0,9 | 3,0 |
| ROE % | -4,5 | 3,6 |
| Net Margin % | -2,4 | 3,8 |
| Rev Growth 5Y % | 10,4 | 9,9 |
| D/E | 2,4 | 0,2 |
Objectif de Cours des Analystes
Hold
18,85 €
+56.4%
Low: 16,25 €
High: 21,00 €
P/E Prévisionnel
28,49
BPA Prévisionnel
0,42 €
Croissance BPA (est.)
+0,0%
CA Est.
3,41B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,85 €
0,82 € – 0,90 €
|
4,52B | 1 |
| FY2028 |
0,59 €
0,57 € – 0,62 €
|
4,09B | 1 |
| FY2027 |
0,49 €
0,17 € – 0,90 €
|
3,59B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | 0,30 € | 0,12 € | -60,6% |
| 2025-11-10 | 0,19 € | 0,13 € | -31,6% |
| 2025-08-05 | 0,16 € | 0,17 € | +6,3% |
| 2025-05-12 | 0,08 € | 0,04 € | -50,0% |
| 2025-03-03 | 0,38 € | 0,44 € | +15,8% |
| 2024-11-12 | 0,25 € | 0,19 € | -24,0% |
| 2024-08-06 | 0,21 € | 0,21 € | 0,0% |
| 2024-05-07 | 0,07 € | 0,10 € | +42,9% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 10,43% annually over 5 years — strong growth
Debt/Equity of 2,35 — high leverage
Generating 195,60M in free cash flow
PEG of 0,47 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,19%
Capital efficient — spends only 2,38% of revenue on capex
Croissance
Revenue Growth (5Y)
10,43%
Revenue (1Y)6,24%
Earnings (1Y)N/A
FCF Growth (3Y)-2,32%
Qualité
Return on Equity
-4,45%
ROIC5,09%
Net Margin-2,35%
Op. Margin11,77%
Sécurité
Debt / Equity
2,35
Current Ratio1,87
Interest Coverage1,43
Valorisation
P/E Ratio
-20,02
Forward P/E28,49
P/B Ratio0,91
EV/EBITDA13,72
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,24% | Revenue Growth (3Y) | 9,82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10,43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,31B | Net Income (TTM) | -77,90M |
| ROE | -4,45% | ROA | -0,95% |
| Gross Margin | 23,12% | Operating Margin | 11,77% |
| Net Margin | -2,35% | Free Cash Flow (TTM) | 195,60M |
| ROIC | 5,09% | FCF Growth (3Y) | -2,32% |
| Safety | |||
| Debt / Equity | 2,35 | Current Ratio | 1,87 |
| Interest Coverage | 1,43 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -20,02 | Forward P/E | 28,49 |
| P/B Ratio | 0,91 | P/S Ratio | 0,47 |
| PEG Ratio | 0,47 | Forward PEG | N/A |
| EV/EBITDA | 13,72 | Fwd EV/EBITDA | 9,16 |
| Forward P/S | 0,46 | Fwd Earnings Yield | 3,51% |
| FCF Yield | 12,54% | ||
| Market Cap | 1,56B | Enterprise Value | 5,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,31B | 3,11B | 2,74B | 2,54B | 2,23B |
| Net Income | -77,90M | -168,10M | -11,90M | -54,60M | -70,90M |
| EPS (Diluted) | -0,61 | -1,33 | -0,09 | -0,59 | -1,12 |
| Gross Profit | 765,00M | 745,60M | 647,50M | 574,90M | 491,40M |
| Operating Income | 389,50M | 348,80M | 328,00M | 345,20M | 302,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,24B | 7,89B | 6,88B | 6,68B | 6,12B |
| Total Liabilities | 4,72B | 4,25B | 3,51B | 3,40B | 3,82B |
| Shareholders' Equity | 1,71B | 1,79B | 1,99B | 2,00B | 1,09B |
| Total Debt | 4,02B | 3,70B | 3,06B | 2,93B | 3,29B |
| Cash & Equivalents | 239,90M | 269,50M | 195,90M | 282,90M | 389,90M |
| Current Assets | 1,15B | 1,12B | 895,00M | 921,00M | 946,10M |
| Current Liabilities | 615,50M | 624,40M | 523,00M | 493,40M | 536,80M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#310 of 619
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026